Although the tetranucleotide repeat polymorphism is the most widely studied of all these variants in the CYP19 gene, there are a lot of inconsistencies in reports in various populations with respect to breast cancer susceptibility [5-9]. This evidence concerns the gene CYP19A1 and breast carcinoma.